Tortoise Investment Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-119
Closed -$11.6K 398
2025
Q3
$11.6K Buy
119
+4
+3% +$414 ﹤0.01% 593
2025
Q2
$12.4K Buy
115
+71
+161% +$7.18K ﹤0.01% 575
2025
Q1
$4.44K Sell
44
-447
-91% -$45K ﹤0.01% 649
2024
Q4
$43.9K Buy
491
+85
+21% +$7.48K ﹤0.01% 438
2024
Q3
$34K Buy
406
+273
+205% +$21.5K ﹤0.01% 477
2024
Q2
$10.2K Buy
133
+66
+99% +$4.83K ﹤0.01% 627
2024
Q1
$4.59K Buy
67
+24
+56% +$1.54K ﹤0.01% 684
2023
Q4
$2.49K Hold
43
﹤0.01% 684
2023
Q3
$2.27K Sell
43
-7
-14% -$367 ﹤0.01% 683
2023
Q2
$2.71K Hold
50
﹤0.01% 666
2023
Q1
$2.5K Sell
50
-29
-37% -$1.37K ﹤0.01% 677
2022
Q4
$3.65K Hold
79
﹤0.01% 639
2022
Q3
$3K Buy
+79
New +$3.17K ﹤0.01% 641

Other funds holding BSX

Tortoise Investment Management's BSX Position: Q4 2025 in Review

Tortoise Investment Management sold out of Boston Scientific (BSX) in Q4 2025, closing a stake of 119 shares — an estimated $11.6K sold.

Tortoise Investment Management first reported a position in BSX in Q3 2022 and held it in 13 quarters. The position peaked at $43.9K in Q4 2024. 1,787 funds tracked by Wall St. Rank hold BSX as of Q4 2025.

  • Tortoise Investment Management reported no remaining Boston Scientific position as of Q4 2025 after selling out during the quarter.
  • Tortoise Investment Management sold 119 Boston Scientific shares in Q4 2025, an estimated $11.6K.
  • Tortoise Investment Management first reported a position in Boston Scientific in Q3 2022 and held it in 13 quarters.
  • Tortoise Investment Management's Boston Scientific position peaked at $43.9K in Q4 2024.
  • 1,787 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2025.

Based on Tortoise Investment Management's 13F filing for Q4 2025, filed 6 Feb 2026.